Local News: Los Angeles, CA 

 | 

Sign Up

 | 

Sign In

Advertisment

Actos, Pioglitazone News

News on Actos, Pioglitazone (generic) continually updated from thousands of sources around the net.

Wednesday Jul 1 | Med Ad News

Takeda Submitted an Application for an Additional Indication of...

An NDA for alogliptin monotherapy was submitted on September 29, 2008 and is now under evaluation by regulatory authorities.

Comment?

Related Topix: Medicine, Medication, Diabetes, Health, Insulin (generic), Humulin, Novolin

Tue Jun 30, 2009

US News & World Report

Health Buzz: Diabetes Drug Setback and Other Health News

The U.S. Food and Drug Administration postponed the approval of alogliptin, a drug to treat type 2 diabetes.

Comment?

Related Topix: Medicine, Health, Diabetes, Food and Drug Administration, Medication

Mon Jun 29, 2009

EMaxHealth

FDA Requires More Data from Takeda on Alogliptin

Takeda Pharmaceuticals has received a request from the U.S. Food & Drug Administration for additional safety studies on SYR-322, also known by the general name alogliptin, used for diabetes treatment.

Comment?

Related Topix: Food and Drug Administration, Medicine, Diabetes, Health

Sat Jun 27, 2009

Chicago Tribune

FDA wants additional study of diabetes drug

In a blow to the diabetes treatment franchise of a Deerfield drug maker, the U.S. Food and Drug Administration has asked Takeda Pharmaceuticals North America Inc.

Comment?

Related Topix: Medicine, Diabetes, Health, Food and Drug Administration, Insulin (generic), Humulin, Novolin, Medication, Avandia, Rosiglitazone (generic), Business News

Fri Jun 26, 2009

Bloomberg Business News

Takeda Hurt by Star Drug's Patent Expiry, FDA Delay for New Diabetes Pill

Takeda Pharmaceutical Co. a s new diabetes drug faces a likely delay by U.S. regulators this week, leaving the company without a contender to replace sales of its star diabetes pill Actos when its patent expires in 18 months.

Comment?

Related Topix: Medicine, Diabetes, Health, Food and Drug Administration, World News, Japan

Thu Jun 18, 2009

In Diabetes Today

Diabetes Drug Shows Promise in Multiple Sclerosis

Treatment with the diabetes drug Actos, known technically as pioglitazone, seems to reduce brain shrinkage and may have other beneficial effects in people with multiple sclerosis , researchers report.

Comment?

Related Topix: Medicine, Multiple Sclerosis, Diabetes, Health, Medication, University of Illinois Chicago

Tue Jun 16, 2009

EurekAlert!

TGen and USC researchers find genetic markers to help fight diabetes

June 16, 2009 - Translational Genomics Research Institute scientists have identified five genetic biomarkers that could help lead to improved treatments, with fewer side-effects, for patients with diabetes.

Comment?

Related Topix: Medicine, Medication, University of Southern California, Insulin (generic), Humulin, Novolin

Sun Jun 14, 2009

Diabetes Self Management

Thiazolidinediones

A class of oral diabetes drugs, commonly nicknamed "glitazones." Unlike the traditional oral drugs called sulfonylureas , which lower blood glucose levels by making the pancreas secrete more insulin, the thiazolidinediones work by helping the body's tissues to use insulin more effectively and by suppressing glucose production by the liver.

Comment?

Related Topix: Medicine, Health, Diabetes, Insulin (generic), Humulin, Novolin, Medication, Avandia, Rosiglitazone (generic)

Fri Jun 12, 2009

RNweb

ADA 2009: PPAR gamma agonists protect kidney from age-related and hypertension-induced scarring

Proliferator-activated receptor gamma agonists appear to protect against and halt progression of both hypertension-related and age-related glomerulosclerosis, reports Agnes B. Fogo, professor of pathology, medicine, and pediatrics, Vanderbilt University, Nashville, TN .

Comment?

Related Topix: Medicine, Medication, Nursing

Thu Jun 11, 2009

MediLexicon

InteKrin Therapeutics Announces INT131 Phase 2a Results At The 2009...

InteKrin Therapeutics Inc presented Phase 2a clinical study results at the American Diabetes Association annual meeting in New Orleans demonstrating that once a day oral treatment with INT131 provides anti-diabetic efficacy consistent with maximal dose thiazolidinedione therapy but with less hematocrit reduction and weight gain.

Comment?

Related Topix: Medicine, Diabetes, Health, Fasting, Medication, Insulin (generic), Humulin, Novolin

Medical News Today

Study Shows Combination Therapy With Januvia™ And Pioglitazone ...

New investigational data presented at the American Diabetes Association 69th Annual Scientific Sessions showed that initial combination therapy with 'Januvia' and pioglitazone* substantially improved blood sugar control.

Comment?

Related Topix: Medicine, Medication, Diabetes, Health, Biotech, Merck , Healthcare Industry, Metformin (generic), Glucophage, Insulin (generic), Humulin, Novolin, Fasting

Wed Jun 10, 2009

MediLexicon

Promising Results With Aleglitazar, A New Treatment Drug For Type 2 Diabetes

The results from the phase II SYNCHRONY study are published in an article Online First and in a future edition of The Lancet .

Comment?

Related Topix: Medicine, Diabetes, Health, Avandia, Rosiglitazone (generic), Medication, UC San Diego

Tue Jun 09, 2009

MediLexicon

VeroScience Presents Data On Newly FDA Approved Drug Cycloset At...

VeroScience, in collaboration with S2 Therapeutics, announced the presentation of clinical and preclinical data at the American Diabetes Association 69th Scientific Sessions on Cycloset, a novel treatment for patients with Type 2 diabetes.

Comment?

Related Topix: Healthcare Law, Law, Medicine, Diabetes, Health, Avandia, Rosiglitazone (generic), Medication, Insulin (generic), Humulin, Novolin

Mon Jun 08, 2009

Zacks Analyst Blog

Amylin Update Post ADA Meeting

Earnings Estimates Revisions They're the most powerful force driving stock prices, and the key to the Zacks Rank's market-beating track record.

Comment?

Related Topix: Biotech, Medicine, Amylin Pharmaceuticals, Healthcare Industry, Diabetes, Health, Fasting, Merck , Medication

StartupJournal

Diabetes Study Questions Treatments

NIH Finds Patients With Heart Disease Fare Equally Well Without Stents and Drugs Such as Avandia, Actos By KEITH J. WINSTEIN Aggressive use of expensive diabetes drugs and medical devices called stents did no better than cheaper treatments at preventing deaths, heart attacks or strokes in a large study of diabetics with heart disease.

Comment?

Related Topix: Medicine, Diabetes, Health, Avandia, Rosiglitazone (generic), Medication, Boston Scientific, Medical Equipment, Healthcare Industry, Biotech

Drugs.com

Research: Popular Diabetes Medications Associated with Increase in Bone Fractures

Research presented at the American Diabetes Association's 69th Scientific Sessions points to increased risk for people with diabetes associated with two widely used drug classes; while another study shed new light on a different class of drugs that faced increased scrutiny from the US Food and Drug Administration .

Comment?

Related Topix: Medicine, Diabetes, Health, Food and Drug Administration, Medco Health Solution, Insurance, Avandia, Rosiglitazone (generic)

RNweb

ADA 2009: Combination treatments achieve lower HbA1c, more patients reach goal

Initial type 2 diabetes treatment with a combination of sitagliptin and pioglitazone produced more robust hemoglobin A1c lowering than either agent alone, and sitagliptin as add-on therapy to insulin with or without metformin also showed significantly enhanced HbA1c reduction compared to insulin alone.

1 comment

Related Topix: Medicine, Medication, Diabetes, Health, Insulin (generic), Humulin, Novolin, Metformin (generic), Glucophage, Nursing

Sun Jun 07, 2009

The Post Chronicle

Once-Weekly Amylin Drug Tops Januvia, Actos: Study

The high-profile experimental once-weekly injectable diabetes drug from Amylin Pharmaceuticals Inc and Eli Lilly and Co proved superior to the widely used medicines Actos and Januvia in a clinical trial, according to data presented on Saturday.

Comment?

Related Topix: Medicine, Biotech, Amylin Pharmaceuticals, Healthcare Industry, Eli Lilly

Sat Jun 06, 2009

Bloomberg Business News

Merck's Diabetes Drug Januvia, Paired with Insulin, Improves Sugar Control

Merck & Co.a s diabetes pill Januvia, as part of a combination therapy, improved blood-sugar levels more than taking either insulin or Takeda Pharmaceutical Co.a s Actos alone, two company studies said.

Comment?

Related Topix: Medicine, Diabetes, Health, Insulin (generic), Humulin, Novolin, Whitehouse Station, NJ

Freshnews

In Investigational Studies, New Uses of Januviaa a a in Combination with Other Diabetes Medicines Resulted in Significant Blood Sugar-Lowering Efficacy for Patients with Type 2 Diabetes

In two new investigational studies evaluating the efficacy and tolerability of Merck & Co., Inc.

Comment?

Related Topix: Medicine, Diabetes, Health, Biotech, Merck , Healthcare Industry, Insulin (generic), Humulin, Novolin, Medication, Metformin (generic), Glucophage, Healthcare Law, Law

↑ Back to top

More Actos, Pioglitazone News

Archives

Read more articles in the Actos, Pioglitazone News Archives.

For up to the minute news, check out the Actos, Pioglitazone News Wire.

Want to add Actos, Pioglitazone News headlines to your web site? Get the widget here.

RSS icon mobile icon

Actos, Pioglitazone (generic) Photos

Vote on and add your comments to the latest Actos, Pioglitazone (generic) photos from around the world

Actos, Pioglitazone News Editors

RoboBlogger

I edit this news page on Topix when no humans are available to help.

People just like you make Actos, Pioglitazone News on Topix better every day. If you're interested in becoming an editor, apply today!

Edits History | Editor Blog

Also on Topix